MNOV
MediciNova Inc
2.70$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
MediciNova Inc (MNOV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -9.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.9 | -14 | -23 | -34 | -44 | -21 | -17 | -18 | -13 | -12 | -11 | 0.8 | -7.2 | -6.5 | -6.9 | -9.1 | -9.1 | -11 | -9.4 | -13 | -7.4 | -11 | -9.8 | |
| 0.0 | 0.0 | -0.7 | -0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 34,294 | 439 | 2,090 | – | 3.2 | 2.4 | 2.0 | 1.4 | 0.7 | 1.2 | 1.6 | 2.0 | 4.0 | 4.5 | 6.3 | 4.1 | 3.2 | 1.7 | 0.6 | 0.7 | 1.2 | 0.8 | |
| – | – | – | – | – | – | – | – | 1.4 | 0.7 | 1.2 | 1.6 | 2.1 | 4.0 | 4.5 | 6.3 | 4.1 | 3.2 | 1.7 | 0.8 | – | – | – | |
| 0.2 | 0.4 | 3.1 | -0.2 | 0.8 | -3.2 | 1.1 | -1.0 | 2.3 | -0.9 | -7.9 | 8.3 | -0.4 | 0.3 | -0.3 | -0.8 | -0.3 | -0.4 | -1.2 | 0.3 | 0.1 | -1.0 | 1.2 | |
| 0.0 | 0.3 | 1.0 | 0.2 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -1.1 | -11 | -89 | 5.8 | 44 | 22 | -1.1 | 28 | 0.0 | -0.8 | 0.0 | 0.0 | 0.0 | -0.1 | -84 | 0.6 | 0.0 | 0.0 | 0.0 | -40 | 40 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | 37 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | -1.1 | -0.1 | -1.4 | – | 87 | 82 | 0.0 | 0.0 | 59 | 13 | 4.2 | 18 | 0.1 | 0.1 | 0.1 | 0.0 | -0.2 | -0.1 | – | – | – | – | |
| – | – | – | – | – | – | – | – | -15 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10.0 | 59 | 111 | -1.1 | 11 | 0.1 | 18 | -0.9 | 0.2 | 1.5 | 13 | 4.2 | 18 | 8.7 | 11 | 43 | 11 | 7.1 | 21 | 0.0 | 32,461 | 0.0 | 0.2 | |
| 3.0 | 35 | -1.1 | -29 | 10 | 0.5 | -0.1 | 9.0 | -13 | -11 | 2.7 | 5.0 | 10 | 2.0 | 3.9 | 34 | 1.5 | -3.8 | 11 | -53 | 32 | -11 | -9.6 | |
| -5.9 | -14 | -24 | -34 | -44 | -21 | -17 | -18 | -13 | -12 | -11 | 0.8 | -7.2 | -6.6 | -6.9 | -9.1 | -9.1 | -11 | -9.4 | -13 | -7.5 | -11 | -9.8 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.